Characteristic | Optimal glycemic control | Suboptimal glycemic control | P |
---|---|---|---|
(n = 505) | (n = 201) | ||
Age (years) | 32.0 (28.0–36.0) | 33.0 (28.0–37.0) | 0.514 |
≥ 35 years old | 190 (37.6) | 82 (40.8) | 0.434 |
Multiparity | 294 (58.2) | 149 (74.1) | < 0.001 |
Prepregnancy BMI (kg/m2) | 22.6 (20.4–25.7) | 26.3 (23.0–30.7) | < 0.001 |
Overweight or obese BMI (≥ 25 kg/m2) | 146 (28.9) | 119 (59.2) | < 0.001 |
History of T2DM in any first-degree relatives | 135 (26.7) | 69 (34.3) | 0.045 |
GCT value (mg/dL) | 164.0 (152.0–182.0) | 177.0 (156.5–210.0) | < 0.001 |
100-g OGTT (mg/dL) | |||
Fasting value | 82.0 (75.0–88.8) | 96.0 (88.0–106.0) | < 0.001 |
1-hour value | 191.0 (180.0–204.0) | 207.0 (191.0–232.0) | < 0.001 |
2-hour value | 173.0 (160.0–188.0) | 183.0 (167.0–213.0) | < 0.001 |
3-hour value | 146.5 (127.0–160.0) | 148.0 (125.0–174.0) | 0.134 |
Gestational age at GDM diagnosis (weeks) | 29.0 (17.0–31.0) | 18.5 (10.0–29.0) | < 0.001 |
Early-onset GDM (< 24 weeks) | 156 (30.9) | 121 (60.2) | < 0.001 |
Insulin use | 12 (2.4) | 82 (40.8) | < 0.001 |
Type of insulin | |||
Rapid-acting insulin | 1 (0.2) | 10 (5.0) | < 0.001 |
Short-acting insulin | 0 (0) | 22 (10.9) | < 0.001 |
Intermediate-acting insulin | 4 (0.8) | 20 (10.0) | < 0.001 |
Premixed insulin | 8 (1.6) | 51 (25.4) | < 0.001 |
Units of insulin used in pregnancy | 333 (130–411) | 946 (303–1758) | 0.006 |
Average plasma glucose during pregnancy (mg/dL) | |||
Fasting value | 78.9 (74.0–84.0) | 92.5 (84.6–100.9) | < 0.001 |
2-hour postprandial value | 98.0 (89.5–106.0) | 119.5 (111.4–132.5) | < 0.001 |
Neonatal birth weight (g) | 3220 (2905–3549) | 3516 (3039–3840) | < 0.001 |